Vertex Pharmaceuticals | VRTX - EPS Earnings Per Share


Vertex Pharmaceuticals reported $4.76 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 4.76 4.88 4.80 Nov/02
FY2026Q2 Jun/2026 4.73 4.72 4.52 Aug/03
FY2026Q1 Mar/2026 4.47 4.43 4.06 May/04
FY2025Q4 Dec/2025 5.03 5.12 3.98 Feb/12
FY2025Q3 Sep/2025 4.80 4.62 4.38 Nov/03




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amgen USD 6.29 1.14 Jun/2026
Arrowhead Research USD -1.36 0.43 Jun/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
Insmed USD -0.46 0.4 Sep/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
J&J USD 2.7 0.2 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Moderna USD -1.97 1.43 Jun/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.46 0.05 Sep/2026
Pfizer USD 0.77 0.02 Jun/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 3.55 1.46 Sep/2026
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
United Therapeutics USD 7.27 1.45 Jun/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026